Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001615774-18-010012

Director acquired 27,027 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Unanue Peter Director 2018-09-24 Grant or award +27,027 $1.85 $50,000 96,627 D
Derivatives
Unanue Peter Director 2018-09-24 Grant or award · Common Stock Purchase Warrant +27,027 27,027 D
Loading xslF345X03/s112893_form4.xml…